ISB News

The Women of ISB: Phyliss Lee, Software Engineer

Name:

Phyliss Lee

Lab:

Shmulevich

Research:

I help create websites and pages for the Cancer Genomics Cloud Pilot Project. The tools that I’m building will not only help scientists gather petabytes of cancer genomic data faster, but will also help them run analyses and visualize the data graphically. What I’m building has the potential to reach millions of people.

Working at ISB:

What I like about being in science is that there are truly no stupid questions. Working at ISB has thrown me into the deep end of biology. I’d never taken a biology class in my life. But the scientists here are so passionate and are happy to talk to me about their research. I’m also so fortunate to work on a team that’s about 50-50 female developers, software engineers.

Advice for future software engineers:

I definitely encourage young girls to start coding. It not only helps you build cool things, but it also helps you think about everyday decisions in a more rational manner.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.